VEGFA variants are associated with pre-school lung function, but not neonatal lung function

Clinical and Experimental Allergy

Volumn 43, Issue 11, 2013, Pages 1236-1245

  Kreiner Moller E ^a   Chawes, B L K ^a   Vissing, N H ^a   Koppelman, G H ^b   Postma, D S ^c   Madsen, J S ^d   Olsen, D A ^d   Baty, F ^a   Vonk, J M ^c   Kerkhof, M ^c   Sleiman, P ^e   Hakonarsson, H ^e   Mortensen, L J ^a   Poorisrisak, P ^a   Bisgaard, H ^a   Bonnelykke K ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LILLEBAELT HOSPITAL   (Denmark)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Asthma; Child; Infant; Respiratory function tests; Vascular endothelial growth factor A

Indexed keywords

VASCULOTROPIN A;

ARTICLE; ASTHMA; BLOOD LEVEL; BRONCHUS HYPERREACTIVITY; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; GENE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MAXIMAL MID EXPIRATORY FLOW; POSTNATAL DEVELOPMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOMATOLOGY; VEGFA GENE;

ASTHMA; CHILD; INFANT; RESPIRATORY FUNCTION TESTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

AGE FACTORS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD, PRESCHOOL; FEMALE; GENETIC VARIATION; HUMANS; INFANT, NEWBORN; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84886305972     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12188     Document Type: Article

References (40)

1. Moffatt MF, Gut IG, Demenais F et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363:1211-21.
2. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011; 128:451-62.
3. Barbato A, Turato G, Baraldo S et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174:975-81.
4. Turato G, Barbato A, Baraldo S et al. Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med 2008; 178:476-82.
5. Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 2010; 65:946-58.
6. Lee CG, Link H, Baluk P et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004; 10:1095-103.
7. Tuder RM, Yun JH. Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol 2008; 8:255-60.
8. Sharma S, Murphy AJ, Soto-Quiros ME et al. Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness. Eur Respir J 2009; 33:1287-94.
9. Lachheb J, Chelbi H, Ben Dhifallah I, Ammar J, Hamzaoui K, Hamzaoui A. Association of vascular endothelial growth factor polymorphisms with asthma in Tunisian children. Gene Regul Syst Bio 2008; 2:89-96.
10. Abdel-Rahman AM, El-Sahrigy SA, Bakr SI. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 2006; 129:266-71.
11. Hossny E, El-Awady H, Bakr S, Labib A. Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma. Pediatr Allergy Immunol 2009; 20:89-96.
12. Lee Chung H, Kim SY, Kim SG. Vascular endothelial growth factor and plasminogen activator inhibitor-1 in children with recurrent early wheeze. J Allergy Clin Immunol 2007; 119:1541-2.
13. Yoo Y, Choi IS, Byeon JH et al. Relationships of methacholine and adenosine monophosphate responsiveness with serum vascular endothelial growth factor in children with asthma. Ann Allergy Asthma Immunol 2010; 104:36-41.
14. Kato M, Yamada Y, Maruyama K, Hayashi Y. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Int Arch Allergy Immunol 2010; 152(Suppl 1):62-6.
15. Simpson A, Custovic A, Tepper R et al. Genetic variation in vascular endothelial growth factor-a and lung function. Am J Respir Crit Care Med 2012; 185:1197-204.
16. Bisgaard H. The Copenhagen Prospective Study on Asthma in Childhood (COPSAC): design, rationale, and baseline data from a longitudinal birth cohort study. Ann Allergy Asthma Immunol 2004; 93:381-9.
17. Brunekreef B, Smit J, de Jongste J et al. The prevention and incidence of asthma and mite allergy (PIAMA) birth cohort study: design and first results. Pediatr Allergy Immunol 2002; 13(Suppl 15):55-60.
18. Bisgaard H, Bonnelykke K, Sleiman PM et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med 2009; 179:179-85.
19. International HapMap Consortium The International HapMap Project. Nature 2003; 426:789-96.
20. Loland L, Bisgaard H. Feasibility of repetitive lung function measurements by raised volume rapid thoracoabdominal compression during methacholine challenge in young infants. Chest 2008; 133:115-22.
21. Bisgaard H, Loland L, Holst KK, Pipper CB. Prenatal determinants of neonatal lung function in high-risk newborns. J Allergy Clin Immunol 2009; 123:651-7, 657.e1-4.
22. Loland L, Buchvald FF, Brydensholt Halkjær L et al. Sensitivity of bronchial responsiveness measurements in young infants. Chest 2006; 129:669.
23. Chawes BL, Kreiner-Moller E, Bisgaard H. Upper and lower airway patency are associated in young children. Chest 2010; 137:1332-7.
24. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006; 354:1998-2005.
25. Bisgaard H, Hermansen MN, Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-95.
26. Bisgaard H, Pipper CB, Bonnelykke K. Endotyping early childhood asthma by quantitative symptom assessment. J Allergy Clin Immunol 2011; 127:1155-64 e1152.
27. Sorensen M, Bisgaard H, Stage M, Loft S. Biomarkers of exposure to environmental tobacco smoke in infants. Biomarkers 2007; 12:38-46.
28. Bottema RW, Postma DS, Reijmerink NE et al. Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE. Eur Respir J 2010; 35:54-63.
29. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-75.
30. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5.
31. Team R. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2008. ISBN 3.
32. Yuan HY, Chiou JJ, Tseng WH et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006; 34:W635-41.
33. Garza-Veloz I, Castruita-De la Rosa C, Cortes-Flores R et al. No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth 2011; 11:35.
34. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12:1232-5.
35. Talar-Wojnarowska R, Gasiorowska A, Olakowski M et al. Vascular endothelial growth factor (VEGF) genotype and serum concentration in patients with pancreatic adenocarcinoma and chronic pancreatitis. J Physiol Pharmacol 2010; 61:711-6.
36. Awata T, Inoue K, Kurihara S et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51:1635-9.
37. Shahbazi M, Fryer AA, Pravica V et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13:260-4.
38. Lambrechts D, Storkebaum E, Morimoto M et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34:383-94.
39. Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 2004; 10:RA89-98.
40. Compernolle V, Brusselmans K, Acker T et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002; 8:702-10.